Sfoglia per AUTORE
YOH K
Collezione AOU San Luigi di Orbassano
Items : 1
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2019 Dec;20(12):1655-1669. doi: 10.1016/S1470-2045(19)30634-5. Epub 2019 Oct 4.
2019
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Au KH; Moro-Sibilot D; Shih JY; Yoh K; Imamura F; Nadal E; Novello S; Park K; Chiu CH; Paz-Ares L; Ponce Aix S; Nishio M; Seto T; Garon EB; Nakagawa K; Enatsu S; Zimmermann A; Frimodt-Moller B; Visseren-Grul C; Reck M;